Business

Leap Therapeutics stock hits 52-week low at $0.4 amid sharp decline




Leap Therapeutics stock hits 52-week low at $0.4 amid sharp decline



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.